OXY vs FANG vs DVN
161 measures in 16 categories, one definition each, computed from filings and market data.
OXY68.5
Occidental Petroleum Corporation
Energy · Oil & Gas Exploration & Production
$62.38 +2.84%$62.4B mkt cap
Score DNA
FANG49.7
Diamondback Energy, Inc.
Energy · Oil & Gas Exploration & Production
$203.95 +4.27%$57.1B mkt cap
Score DNA
DVN54.3
Devon Energy Corporation
Energy · Oil & Gas Exploration & Production
$50.73 +3.03%$55.8B mkt cap
Score DNA
Price, rebased to 100 three years ago
OXY FANG DVN · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | OXY | FANG | DVN |
|---|---|---|---|
| Insider open-market buys, 180d | 1 | 0 | 1 |
| Insider $ bought, 180d | $0.25M | — | $0.20M |
| Congress purchases, 180d | 0 | 0 | 2 |
| Last Congress purchase | — | — | 2026-04-09 |
| 13F net change in holders | −61 | −2 | +209 |
| ETFs adding shares, 30d | 929 | 1,178 | 1,037 |
| ETFs trimming, 30d | 604 | 735 | 860 |
| Net ETF funds, 30d | +325 | +443 | +177 |
Valuation
16 measures| Measure | OXY | FANG | DVN |
|---|---|---|---|
| P/E (TTM) | 8.6x
24th
|
36.0x
91st
|
17.0x
76th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 15.89 | — | — |
| Price / sales | 2.5x
66th
|
3.3x
81st
|
2.8x
72nd
|
| Price / book | 1.5x
52nd
|
1.5x
57th
|
1.3x
39th
|
| Price / tangible book | 1.2x
43rd
|
1.3x
48th
|
0.9x
15th
|
| Price / free cash flow | 11.7x
59th
|
8.8x
35th
|
32.6x
92nd
|
| Price / operating cash flow | 5.7x
70th
|
5.6x
65th
|
6.5x
80th
|
| Enterprise value | $72.8B
96th
|
$69.3B
94th
|
$66.5B
91st
|
| EV / sales | 2.9x
60th
|
4.0x
81st
|
3.4x
77th
|
| EV / EBITDA | 5.2x
34th
|
9.7x
75th
|
7.5x
66th
|
| EV / EBIT | 11.5x
67th
|
37.1x
94th
|
14.0x
73rd
|
| EV / free cash flow | 13.7x
57th
|
10.7x
43rd
|
38.8x
89th
|
| Earnings yield | 11.6%
83rd
|
2.8%
34th
|
5.9%
45th
|
| FCF yield | 8.5%
53rd
|
11.4%
72nd
|
3.1%
28th
|
| Operating cash flow yield | 17.6%
32nd
|
17.8%
36th
|
15.4%
21st
|
| Graham number (per share) | $81.55
79th
|
$130.78
85th
|
$59.05
59th
|
Profitability (TTM)
12 measures| Measure | OXY | FANG | DVN |
|---|---|---|---|
| Gross margin | 43.4%
40th
|
44.5%
43rd
|
34.0%
23rd
|
| EBITDA margin | 55.5%
62nd
|
41.7%
36th
|
45.1%
45th
|
| Operating margin | 23.0%
45th
|
27.7%
60th
|
23.5%
49th
|
| EBIT margin | 25.1%
49th
|
10.9%
36th
|
24.2%
45th
|
| Net margin | 28.8%
85th
|
9.3%
30th
|
16.7%
45th
|
| NOPAT margin | 16.9%
43rd
|
22.7%
57th
|
18.4%
45th
|
| FCF margin | 21.1%
53rd
|
38.0%
81st
|
8.7%
30th
|
| Operating cash flow margin | 43.6%
34th
|
59.3%
77th
|
43.9%
36th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 4.1%
32nd
|
1.7%
4th
|
2.2%
9th
|
| Stock comp / revenue | 0.0%
0th
|
0.1%
19th
|
0.6%
36th
|
| Effective tax rate | 26.6%
89th
|
18.0%
26th
|
21.9%
76th
|
Returns on capital
11 measures| Measure | OXY | FANG | DVN |
|---|---|---|---|
| ROE (on average equity) | 18.7%
70th
|
4.1%
28th
|
11.5%
39th
|
| ROA | 8.8%
68th
|
2.2%
30th
|
6.4%
40th
|
| ROIC | 8.1%
40th
|
7.8%
38th
|
6.9%
28th
|
| ROCE | 8.7%
43rd
|
2.9%
32nd
|
7.4%
38th
|
| Return on tangible assets | 7.7%
40th
|
2.6%
32nd
|
9.3%
49th
|
| Cash ROIC (OCF / invested capital) | 21.0%
43rd
|
20.3%
38th
|
16.4%
19th
|
| Gross profitability (GP / assets) | 13.6%
34th
|
10.8%
17th
|
9.3%
9th
|
| ROIC, 3-yr average | 5.5%
30th
|
8.5%
50th
|
10.5%
64th
|
| ROIC, 5-yr average | 9.7%
31st
|
12.7%
38th
|
20.0%
62nd
|
| ROE, 5-yr average | 20.2%
46th
|
17.0%
38th
|
30.0%
82nd
|
| Incremental ROIC | -71.4%
15th
|
-21.0%
20th
|
4.7%
39th
|
Growth
17 measures| Measure | OXY | FANG | DVN |
|---|---|---|---|
| Revenue growth (TTM YoY) | -7.5%
11th
|
22.0%
70th
|
17.0%
57th
|
| Revenue growth (QoQ) | 59.2%
89th
|
31.2%
62nd
|
94.8%
94th
|
| Revenue CAGR, 3 yr | -7.1%
14th
|
27.2%
88th
|
5.3%
57th
|
| Revenue CAGR, 5 yr | 4.9%
3rd
|
31.5%
77th
|
19.3%
49th
|
| Gross profit CAGR, 3 yr | -4.6%
43rd
|
13.6%
79th
|
0.5%
57th
|
| Operating income CAGR, 3 yr | -14.2%
51st
|
-1.1%
76th
|
-8.8%
61st
|
| Net income growth (TTM YoY) | 206.7%
87th
|
-58.7%
0th
|
15.3%
35th
|
| Net income CAGR, 3 yr | 2.4%
86th
|
-22.9%
24th
|
-11.8%
52nd
|
| EPS growth (TTM YoY) | 206.2%
87th
|
-57.1%
0th
|
-22.0%
16th
|
| EPS CAGR, 3 yr | 0.5%
93rd
|
-33.5%
10th
|
-22.4%
41st
|
| EPS CAGR, 5 yr | — | — | 53.8%
77th
|
| FCF growth (TTM YoY) | 10.7%
33rd
|
— | — |
| FCF CAGR, 3 yr | -14.9%
20th
|
56.8%
97th
|
17.3%
73rd
|
| Operating cash flow CAGR, 3 yr | -8.2%
19th
|
17.2%
81st
|
6.6%
60th
|
| Book value CAGR, 3 yr | 10.7%
63rd
|
16.1%
83rd
|
37.1%
95th
|
| Dividend CAGR, 3 yr | 0.9%
75th
|
-9.4%
34th
|
-8.7%
38th
|
| Sustainable growth rate | 14.5%
68th
|
0.3%
15th
|
8.7%
35th
|
Margin history & stability
7 measures| Measure | OXY | FANG | DVN |
|---|---|---|---|
| Gross margin, 3-yr average | 37.8%
32nd
|
46.5%
50th
|
30.3%
16th
|
| Operating margin, 3-yr average | 21.9%
34th
|
38.3%
82nd
|
24.9%
43rd
|
| Net margin, 3-yr average | 18.0%
55th
|
24.8%
75th
|
19.0%
57th
|
| FCF margin, 3-yr average | 17.9%
55th
|
0.1%
18th
|
8.3%
34th
|
| Revenue stability (0-1) | 0.16
20th
|
0.95
82nd
|
0.82
66th
|
| Earnings stability (0-1) | 0.10
43rd
|
0.14
50th
|
0.04
20th
|
| Margin stability (0-1) | 0.67
20th
|
0.83
64th
|
0.82
59th
|
Liquidity (latest quarter)
7 measures| Measure | OXY | FANG | DVN |
|---|---|---|---|
| Cash & short-term investments | $4.2B
94th
|
$462.0M
74th
|
$1.0B
89th
|
| Net cash (− = net debt) | −$10.5B
6th
|
−$12.2B
2nd
|
−$10.7B
4th
|
| Working capital | $3.2B
96th
|
−$3.0B
0th
|
−$2.0B
2nd
|
| Current ratio | 1.41
79th
|
0.47
9th
|
0.72
38th
|
| Quick ratio | 1.13
68th
|
0.45
13th
|
0.67
34th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.53
70th
|
0.08
28th
|
0.14
34th
|
| Defensive interval (days) | 584 days
68th
|
304 days
34th
|
763 days
77th
|
Leverage & solvency (latest quarter)
13 measures| Measure | OXY | FANG | DVN |
|---|---|---|---|
| Total debt | $14.6B
98th
|
$12.6B
94th
|
$11.7B
91st
|
| Debt / equity | 0.35
35th
|
0.33
33rd
|
0.28
30th
|
| Net debt / equity | 0.25
30th
|
0.32
39th
|
0.26
33rd
|
| Debt / assets | 18.2%
34th
|
18.0%
32nd
|
16.6%
26th
|
| Debt / capital | 25.9%
35th
|
25.0%
33rd
|
22.0%
30th
|
| Debt / EBITDA | 1.05
36th
|
1.77
52nd
|
1.33
43rd
|
| Net debt / EBITDA | 0.75
30th
|
1.71
59th
|
1.22
43rd
|
| Interest coverage (EBIT / interest) | 7.5x
62nd
|
7.0x
60th
|
9.3x
67th
|
| Cash interest coverage | 13.0x
54th
|
38.0x
87th
|
16.8x
70th
|
| Debt payback (years of OCF) | 1.3 yrs
48th
|
1.2 yrs
43rd
|
1.4 yrs
50th
|
| Liabilities / assets | 47.3%
51st
|
37.4%
21st
|
41.1%
36th
|
| IS credit model rating | A | A- | BBB |
| Implied credit spread (bps) | 150
32nd
|
175
38th
|
275
47th
|
Efficiency
11 measures| Measure | OXY | FANG | DVN |
|---|---|---|---|
| Asset turnover | 0.31
26th
|
0.24
9th
|
0.38
43rd
|
| Fixed asset turnover | 0.19
2nd
|
0.26
7th
|
0.31
22nd
|
| Inventory turnover | 7.0
14th
|
104.4
90th
|
38.0
67th
|
| Receivables turnover | 7.6
30th
|
10.7
62nd
|
7.9
34th
|
| Days sales outstanding | 48 days
70th
|
34 days
38th
|
46 days
66th
|
| Days inventory outstanding | 52 days
86th
|
3 days
10th
|
10 days
33rd
|
| Days payables outstanding | 95 days
70th
|
28 days
21st
|
35 days
32nd
|
| Cash conversion cycle (days) | 5 days
60th
|
9 days
66th
|
21 days
83rd
|
| Capex / revenue | 22.5%
39th
|
21.3%
35th
|
35.1%
65th
|
| Capex / depreciation | 0.74
35th
|
0.69
28th
|
1.68
85th
|
| Operating expense ratio | 35.6%
68th
|
0.0%
0th
|
21.5%
40th
|
Cash flow & earnings quality
7 measures| Measure | OXY | FANG | DVN |
|---|---|---|---|
| Operating cash flow / net income | 1.51
18th
|
6.40
97th
|
2.62
65th
|
| FCF / net income | 0.73
32nd
|
4.10
94th
|
0.52
24th
|
| FCF / operating cash flow | 48.4%
59th
|
64.1%
77th
|
19.9%
27th
|
| Capex / operating cash flow | 51.6%
42nd
|
35.9%
24th
|
80.1%
73rd
|
| Accruals ratio | -4.5%
87th
|
-12.0%
51st
|
-10.4%
66th
|
| Sloan accruals ratio | -5.9%
81st
|
-9.3%
53rd
|
-13.4%
34th
|
| Earnings quality score (0-1) | 1.00
82nd
|
0.75
0th
|
0.75
0th
|
Scores & forensic checks
15 measures| Measure | OXY | FANG | DVN |
|---|---|---|---|
| IS score | 68
66th
|
50
38th
|
54
43rd
|
| IS profitability | 84
81st
|
59
26th
|
72
62nd
|
| IS growth | 51
39th
|
38
20th
|
63
57th
|
| IS value | 87
87th
|
59
36th
|
83
77th
|
| IS momentum | 80
46th
|
68
33rd
|
89
59th
|
| IS risk (safety) | 50
62nd
|
30
34th
|
30
34th
|
| IS quality | 88
81st
|
81
51st
|
81
49th
|
| IS balance sheet | 71
77th
|
59
55th
|
67
66th
|
| IS earnings quality | 75
85th
|
65
60th
|
63
55th
|
| IS cash flow | 66
55th
|
76
70th
|
46
43rd
|
| Piotroski F-score (0-9) | 7
43rd
|
7
43rd
|
5
15th
|
| Altman Z-score | 1.9
64th
|
1.5
45th
|
1.5
43rd
|
| Beneish M-score | −8.07
2nd
|
−2.72
49th
|
−2.43
62nd
|
| Ohlson O-score | −9.70
28th
|
−9.55
30th
|
−9.55
32nd
|
| IS credit score | 73
68th
|
69
62nd
|
56
51st
|
Size (TTM)
8 measures| Measure | OXY | FANG | DVN |
|---|---|---|---|
| Market cap | $62.4B
96th
|
$57.1B
94th
|
$55.8B
91st
|
| Revenue | $25.2B
94th
|
$17.1B
89th
|
$19.6B
91st
|
| EBITDA | $14.0B
94th
|
$7.1B
89th
|
$8.8B
91st
|
| Net income | $7.3B
98th
|
$1.6B
83rd
|
$3.3B
91st
|
| Free cash flow | $5.3B
94th
|
$6.5B
96th
|
$1.7B
81st
|
| Total assets | $80.4B
98th
|
$70.2B
94th
|
$70.9B
96th
|
| Shareholders' equity | $41.7B
96th
|
$37.9B
94th
|
$41.7B
98th
|
| Employees | 10,412
100th
|
1,762
83rd
|
2,200
89th
|
Price performance
9 measures| Measure | OXY | FANG | DVN |
|---|---|---|---|
| 1 day | +2.8% | +4.3% | +3.0% |
| 1 week | +3.8% | +6.2% | +5.1% |
| 1 month | +5.2% | +3.6% | +4.1% |
| 3 months | +13.1% | +4.4% | +16.6% |
| 6 months | +16.0% | +13.1% | +16.3% |
| Year to date | +47.2% | +33.9% | +36.5% |
| 1 year | +49.8% | +44.7% | +59.5% |
| 3 years, cumulative | +2.6% | +40.9% | +19.7% |
| 5 years, cumulative | +96.7% | +125.5% | +61.2% |
Technicals
4 measures| Measure | OXY | FANG | DVN |
|---|---|---|---|
| RSI 14 | 63.7 | 64.4 | 62.0 |
| From 52-week high | −7.5% | −6.0% | −2.4% |
| From 52-week low | +60.8% | +49.9% | +65.3% |
| Beta | 0.16 | 0.41 | 0.43 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17